TOMOQ OG'RIG'IDAN YURAK NUQSONIGACHA: REVMATIZMNING YASHIRIN YO'LI

Authors

  • Xaydaraliev Saidolim Umarali o’g’li Toshkent davlat tibbiyot universiteti 2-son ichki kasalliklar propedevtika kafedrasi datsenti Author
  • Rajapboyeva Ozoda Shuxrat qizi Author

Abstract

Tomoq og'rig'i eng oddiy kasalliklardan biri, lekin ba'zan uning oqibati yurakda qoladi. 2015-yilda dunyoda taxminan 33,4 million kishida revmatik yurak kasalligi bo'lgan va shu kasallikdan 319 400 kishi vafot etgan (1). 1990–2015-yillarda yoshga moslashtirilgan o'lim ko'rsatkichi 47,8 foizga kamaygan, lekin yuqori ko'rsatkichlar dunyoning eng kambag'al hududlarida saqlanib qolmoqda (1). Kasallik quyidagicha rivojlanadi: streptokokk tomoqni yallig'lantiradi, so'ng organizmning o'z immuniteti yurakka qarshi ishlay boshlaydi, bu holat revmatik isitma deyiladi (2). 

References

1. Watkins DA, et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. N Engl J Med. 2017;377(8):713-22. doi:10.1056/NEJMoa1603693

2. Carapetis JR, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:15084. doi:10.1038/nrdp.2015.84

3. Spinks A, et al. Antibiotics for treatment of sore throat in children and adults. Cochrane Database Syst Rev. 2021;12:CD000023. doi:10.1002/14651858.CD000023.pub5

4. Marijon E, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357(5):470-6. doi:10.1056/NEJMoa065085

5. Gewitz MH, et al. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography. Circulation. 2015;131(20):1806-18. doi:10.1161/CIR.0000000000000205

6. Beaton A, et al. Secondary antibiotic prophylaxis for latent rheumatic heart disease. N Engl J Med. 2022;386(3):230-40. doi:10.1056/NEJMoa2102074

Downloads

Published

2026-09-20